Phase 1 study of oxaliplatin and irinotecan in pediatric patients with refractory solid tumors-Reference-Cited by-同舟云学术

Phase 1 study of oxaliplatin and irinotecan in pediatric patients with refractory solid tumors

Published:2009-04-15 Issue:8 Volume:115 Page:1765-1775
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

McGregor Lisa M.,Spunt Sheri L.,Furman Wayne L.,Stewart Clinton F.,Schaiquevich Paula,Krailo Mark D.,Speights RoseAnne,Ivy Percy,Adamson Peter C.,Blaney Susan M.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference61 articles.

1. Combination of oxaliplatin and irinotecan on human colon cancer cell lines: activity in vitro and in vivo;Guichard;Anticancer Drugs.,2001

2. Platinated DNA adducts enhance poisoning of DNA topoisomerase I by camptothecin;van Waardenburg;J Biol Chem.,2004

3. Preclinical and phase I study of oxaliplatin and topotecan in combination in human cancer;Tortora;Ann Oncol.,2002

4. Phase I clinical and pharmacologic study of weekly cisplatin and irinotecan combined with amifostine for refractory solid tumors;Souid;Clin Cancer Res.,2003

5. Phase I study of combination topotecan and carboplatin in pediatric solid tumors;Athale;J Clin Oncol.,2002

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Absolute neutrophil count clinical trial eligibility criteria for pediatric oncology phase I and phase I/II trials by sponsorship;Pediatric Blood & Cancer;2024-02-26

2. Influence of UGT1A1 *6/*28 Polymorphisms on Irinotecan-Related Toxicity and Survival in Pediatric Patients with Relapsed/Refractory Solid Tumors Treated with the VIT Regimen;Pharmacogenomics and Personalized Medicine;2021-03

3. A Chart Review on the Feasibility and Safety of the Vincristine Irinotecan Pazopanib (VIPaz) Association in Children and Adolescents With Resistant or Relapsed Sarcomas;Frontiers in Oncology;2020-08-06

4. Medulloblastoma in children and adolescents: a systematic review of contemporary phase I and II clinical trials and biology update;Cancer Medicine;2017-10-04

5. A comparison of safety and efficacy of cytotoxic versus molecularly targeted drugs in pediatric phase I solid tumor oncology trials;Pediatric Blood & Cancer;2016-09-22